Company: MVIS
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001641172-25-009765
Chunk: 142

Company: MICROVISION, INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 142
---
 inputs hierarchy classification for liabilities measured at fair value on a recurring basis are summarized below as of March
31, 2025 and December 31, 2024 (in thousands). See Note 5. Investment Securities, Available-For-Sale and Fair Value Measurements,
for discussion of the fair value level hierarchy.

 SCHEDULE
OF HIERARCHY LIABILITIES FAIR VALUE

    As of
    March 31, 2025 
    Level
    1  
    Level
    2  
    Level
    3 
  
    Derivative
    liability 
    $      -  
    $      -  
    $4,867 
  
    Total 
    $-  
    $-  
    $4,867 

    As of
    December 31, 2024 
    Level
    1  
    Level
    2  
    Level
    3 
  
    Derivative
    liability 
    $      -  
    $      -  
    $14,581 
  
    Total 
    $-  
    $-  
    $14,581 

The
table below lists the inputs and assumptions for the Company’s valuations as of March 31, 2025 and December 31, 2024:

 SCHEDULE
OF REVALUATION DERIVATIVE LIABILITY

    March
    31,  
    December
    31, 

    2025  
    2024 
  
    Expected term
    (years) 
     1.5  
     1.75 
  
    Risk-free interest rate 
     3.92% 
     4.18%
  
    Dividend yield 
     0% 
     0%
  
    Volatility 
     82.36% 
     78.02%
  
    Discount rate 
     50.0% 
     50.0%

7.
WARRANT LIABILITY

On
February 3, 2025, the Company entered into a new Securities Purchase Agreement (the “2025 Purchase Agreement”) with an institutional
investor. In exchange for $8.0 million, the Holder agreed to purchase  5,750,225 shares of common stock (the “closing shares”)
and warrants to purchase up to 5,750,225 shares of common stock